14-Nov-2026 21:27:33
ANGGeneral news
ANG LIFESCIENCES Q2 FY27 ; CONS NET PROFIT DOWN 45.78% AT ₹266.05 L (YOY), DOWN 22.05% (QOQ)
REVENUE DOWN 27.05% AT ₹1877.18 L (YOY), DOWN 25.49% (QOQ) EBITDA DOWN 58.10% AT ₹(-339.14) L (YOY), DOWN 324.21% (QOQ) MARGINS AT -18.07% VS -8.66% (YOY), -3.02% (QOQ)
ANG Lifesciences India Ltd
Open attachment